Corpus Intelligence IC Memo — SKYRIDGE MEDICAL CENTER 2026-04-26 04:04 UTC
IC Memo — SKYRIDGE MEDICAL CENTER
Investment Committee Memorandum | TN | 176 beds | Grade C | EBITDA uplift $12.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SKYRIDGE MEDICAL CENTER

CCN 440185 | BRADLEY, TN | 176 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SKYRIDGE MEDICAL CENTER is a 176-bed suburban community hospital in BRADLEY, TN with $163.5M in net patient revenue and a 17.3% operating margin. The hospital serves a payer mix of 22.3% Medicare, 2.5% Medicaid, and 75.2% commercial.

Thesis: Turnaround. Our ML models identify $12.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.3% to 24.6% (+736bps).

Net Revenue HCRIS$163.5M
Current EBITDA COMPUTED$28.2M
Operating Margin COMPUTED17.3%
Occupancy HCRIS68.4%
Revenue / Bed COMPUTED$929K
Net-to-Gross HCRIS9.7%
Distress Probability ML41.7%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
39
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 17.3% places it above the state median. Among 39 size-comparable peers (88-352 beds), the median margin is 0.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (88-352), prioritizing same-state peers. 39 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SKYRIDGE MEDICAL CENTER (Target)TN176$163.5M17.3%
REGIONAL ONE HEALTHTN291$407.9M-50.0%
COOKEVILLE REGIONAL MEDICAL CETN212$372.5M2.1%
SKYLINE MEDICAL CENTERTN350$360.4M15.1%
FORT SANDERS REGIONAL MEDICAL TN304$346.2M-9.4%
HOLSTON VALLEY HOSP & MED CTRTN286$344.6M-7.4%
MAURY REGIONAL HOSPITALTN244$334.0M-9.7%
TENNOVA HEALTHCARE - TURKEY CRTN219$326.2M8.1%
BLOUNT MEMORIAL HOSPITALTN145$326.0M-8.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.4M+210bp18mo
Cost to Collect4.5%2.5%$3.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.0M+122bp9mo
Clean Claim Rate88.0%96.0%$105K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.4M
Cost to Collect
$3.3M
Denial Rate Reduction
$3.2M
A/R Days Reduction
$2.0M
Clean Claim Rate
$105K
Total EBITDA Uplift$12.0M
Current EBITDA$28.2M
+ RCM Uplift+$12.0M
Pro Forma EBITDA$40.2M
Current Margin17.3%
Pro Forma Margin24.6%
WC Released (1x)$6.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$43.4M$306.4M7.06x47.8%
Base (11x exit)10.0x11.0x$43.4M$351.1M8.09x51.9%
Bull Case9.0x11.0x$39.1M$404.9M10.37x59.6%
Bull (12x exit)9.0x12.0x$39.1M$453.3M11.60x63.3%
Bear Case11.0x10.0x$47.7M$232.1M4.86x37.2%
Bear (11x exit)11.0x11.0x$47.7M$270.9M5.67x41.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 39 hospitals with 88-352 beds
  • Same-state prioritization (n=40)
  • Comp margins: P25=-7.7% / P50=0.8% / P75=12.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.